Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation

Introduction: Currently, the regimen with bortezomib plus melphalan and prednisone (VMP) is a standard treatment for multiple myeloma and it is recommended as the first-line therapy for patients with multiple myeloma (MM) ineligible for high-dose chemotherapy with autologous stem-cell transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Buda, Gabriele, Del Giudice, Maria Livia, Antonioli, Elisabetta, Ghio, Francesco, Orciuolo, Enrico, Morganti, Riccardo, Martini, Francesca, Staderini, Michela, Galimberti, Sara, Petrini, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429780/
https://www.ncbi.nlm.nih.gov/pubmed/34513878
http://dx.doi.org/10.3389/fmed.2021.712070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429780/
https://www.ncbi.nlm.nih.gov/pubmed/34513878
http://dx.doi.org/10.3389/fmed.2021.712070

Ejemplares similares